Prospect News: News for Alvogen Pharma US Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, DD only > All stories on Alvogen Pharma US Inc. > Stories on Alvogen Pharma US Inc., DD only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Alvogen Pharma US Inc.

3/19/2025	BKDD	Moody's ups Alvogen, rates loan Caa2
3/14/2025	BKDD	S&P ups Alvogen, rates loan CCC-
3/11/2025	BKDD	Moody's appends Alvogen default rating
3/7/2025	BKDD	S&P downgrades Alvogen
1/13/2025	BKDD	S&P cuts Alvogen, puts on negative watch
1/13/2025	BKDD	Moody’s lowers Alvogen

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.